Article
EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells.
PloS one - 1 Jan 2026
Nakamura Teruo, Shibata Tomohiro, Ito Ken-Ichi
Abstract excerpt
Anaplastic thyroid cancer (ATC) is a rare but highly aggressive malignancy with a dismal prognosis. Although recent advances in targeted therapies have modestly improved survival, the molecular mechanisms driving ATC progression remain incompletely elucidated. Epithelial cell adhesion molecule (EpCAM), a multifunctional cell-surface protein, is implicated in proliferation, migration, and stemness in various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
